World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR926
Date of registration: 10/03/2007
Primary sponsor: Erasmus Medical Center
Public title: Cryo strip versus classic strip of the great saphenous vein.
Scientific title: Cryo strip versus classic strip of the great saphenous vein. - N/A
Date of first enrolment: 1/8/2002
Target sample size: 520
Recruitment status: complete
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=926
Study type:  intervention
Study design:  Randomised: Yes; Masking: None; Control: Active; Group: Parallel; Type: 2 or more arms, randomized  
Countries of recruitment
The Netherlands
Contacts
Name: T.M.A.L.   Klem
Address:  , Berglustlaan 44a 3054BJ Rotterdam The Netherlands
Telephone: t.klem@wxs.nl
Email:
Affiliation: 
Name: T.M.A.L.   Klem
Address:  , Berglustlaan 44a 3054BJ Rotterdam The Netherlands
Telephone: t.klem@wxs.nl
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Patients with primary varicosis and incompetence of the great saphenous vein and saphenofemoral junction (confirmed by duplex). Only patients with C2, C3, C4 varicosis (CEAP-classification).
Exclusion criteria: 1. C5, C6 varicosis;

2. Extreme adipositas (BMI>40);

3. Deep venous occlusion;

4. Incompetence of the small saphenous vein;

5. Aarterial occlusive disease of the legs;

6. Inability to understand the Dutch language;

7. Recurrence of varicosis of the leg.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Great saphenous vein, Great saphenous vein, Venous, Venous surgery, Cryo strip, Classic strip

Intervention(s)
Cryo strip of the great saphenous vein versus classic strip of the great saphnous vein.
Primary Outcome(s)
Recurrence, confirmed by venous duplex.
Secondary Outcome(s)
1. Operation time;

2. Neurological damage after surgery;

3. Quality of life.
Secondary ID(s)
ISRCTN61851091
Source(s) of Monetary Support
Erasmus Medical Center, Sint Franciscus Gasthuis (SFG), Rotterdam, Albert Schweitzer Ziekenhuis, Dordrecht
Secondary Sponsor(s)
Albert Schweitzer Ziekenhuis
Sint Franciscus Gasthuis (SFG)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history